Compared to Estimates, Hims & Hers Health (HIMS) Q4 Earnings: A Look at Key Metrics

Core Insights - Hims & Hers Health, Inc. reported $481.14 million in revenue for Q4 2024, marking a year-over-year increase of 95.1% [1] - The earnings per share (EPS) for the same period was $0.11, compared to $0.01 a year ago, although it fell short of the consensus estimate of $0.12 by 8.33% [1] - The revenue exceeded the Zacks Consensus Estimate of $471.42 million by 2.06% [1] Financial Performance Metrics - Average Order Value (AOV) was $168, surpassing the two-analyst average estimate of $158.71 [4] - Net Orders stood at 2.81 million, matching the two-analyst average estimate [4] - Monthly Online Revenue per Average Subscriber was $73, exceeding the two-analyst average estimate of $71.16 [4] - Subscribers at the end of the period totaled 2.23 million, below the two-analyst average estimate of 2.38 million [4] - Revenue from Wholesale was $10.38 million, slightly above the $10.15 million average estimate based on five analysts [4] - Online Revenue reached $470.76 million, surpassing the $460.87 million average estimate based on five analysts [4] Stock Performance - Shares of Hims & Hers Health have returned +59.6% over the past month, contrasting with the Zacks S&P 500 composite's -0.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]